Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Berenberg Initiates Coverage On Global Medical REIT with Buy Rating, Announces Price Target of $11.75

Author: Benzinga Newsdesk | October 18, 2024 09:34am
Berenberg analyst Kai Klose initiates coverage on Global Medical REIT (NYSE:GMRE) with a Buy rating and announces Price Target of $11.75.

Posted In: GMRE

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist